WOCKHARDT
Back to Income Statement
|
WOCKHARDT Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹3,012 Cr | ₹2,798 Cr | ₹2,651 Cr | ₹3,230 Cr | ₹2,708 Cr |
What is the latest Revenue of WOCKHARDT ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹3,012 Cr |
| Mar2025 | ₹2,798 Cr |
| Mar2024 | ₹2,651 Cr |
| Mar2023 | ₹3,230 Cr |
| Mar2022 | ₹2,708 Cr |
How is Revenue of WOCKHARDT Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,012 Cr | 7.65 | |
| Mar2025 | ₹2,798 Cr | 5.55 | |
| Mar2024 | ₹2,651 Cr | -17.93 | |
| Mar2023 | ₹3,230 Cr | 19.28 | |
| Mar2022 | ₹2,708 Cr | - | |
Compare Revenue of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹29,659.5 Cr | -4.7% | -3.6% | 22.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -2.3% | -3.3% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.3% | 16.3% | 44.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 2.8% | -0.5% | 37.1% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -3.1% | -1.2% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -2.9% | -3% | -3.3% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -4.7% |
-3.6% |
22.7% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses